Clinical Trial Update: Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy

View source ↗

Summary

A clinical trial update on switching or sequential Peginterferon therapy in chronic hepatitis B patients who are on long-term entecavir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Huashan Hospital | Conditions: Chronic Hepatitis B | Status: UNKNOWN